The European Medicines Agency (EMA) has abandoned X, formerly known as Twitter, and moved its communications to Bluesky. This decision reflects a growing unease with Elon Musk’s ownership and direction of the platform, and a desire for a more reliable and less politically charged environment for disseminating crucial health information.
The EMA’s departure isn’t simply a shift to a new social media platform; it’s a strategic move signaling a lack of confidence in X’s ability to consistently deliver vital public health messages. The agency clearly feels it can no longer depend on X as a dependable means of reaching the public with essential information, potentially impacting citizens who rely on the platform for updates on medications and medical decisions.… Continue reading
The Trump administration, through HHS deputy chief of staff Stefanie Spear, has instructed federal health agencies, including the FDA, CDC, and NIH, to halt external communications. This sweeping order encompasses routine reports, website updates, and health advisories, with little explanation provided regarding its scope or duration. While temporary communication pauses are not unprecedented during transitions, the scale of this directive is unusual, raising concerns about potential delays in critical public health information dissemination. The timing is particularly notable given ongoing public health issues like the H5N1 bird flu outbreak.
Read More
In response to the spread of scientific misinformation amplified by social media, particularly during the COVID-19 pandemic, a shift in communication strategies is needed. Public trust in institutions has eroded, necessitating simpler, less technical language in scientific reports. The focus should transition from directive messaging to positive motivation, encouraging personal responsibility for health decisions. Leveraging social media for engagement, rather than solely viewing it as a negative influence, is also crucial.
Read More
Matt Underwood 
John Q. Hosedrinker